Cited by 792Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmune cells in cancer

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Open access

Zhang, Yuanyuan, Chen, Hongyan, Mo, Hongnan, Hu, Xueda, Gao, Ranran, Zhao, Yahui, Liu, Baolin, Niu, Lijuan, Sun, Xiaoying, Yu, Xiao, Wang, Yong, Chang, Qing, Gong, Tongyang, Guan, Xiuwen, Hu, Ting, Qian, Tianyi, Xu, Binghe, Ma, Fei, Zhang, Zemin, Liu, Zhihua·2021·Cancer Cell

DOI 10.1016/j.ccell.2021.09.010

Open this paper in CoChat — free account Open PDF

Abstract

In triple-negative breast cancer (TNBC), the benefit of combining chemotherapy with checkpoint inhibitors is still not very clear. We utilize single-cell RNA- and ATAC-sequencing to examine the immune cell dynamics in 22 patients with advanced TNBC treated with paclitaxel or its combination with the anti-PD-L1 atezolizumab. We demonstrate that high levels of baseline CXCL13 + T cells are linked to the proinflammatory features of macrophages and can predict effective responses to the combination therapy. In responsive patients, lymphoid tissue inducer (LTi) cells, follicular B (Bfoc) cells, CXCL13 + T cells, and conventional type 1 dendritic cells (cDC1) concertedly increase following the combination therapy, but instead decrease after paclitaxel monotherapy. Our data highlight the importance of CXCL13 + T cells in effective responses to anti-PD-L1 therapies and suggest that their reduction by paclitaxel regimen may compromise the clinical outcomes of accompanying atezolizumab for TNBC treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.09.010

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881

Flagged first, then by citations

Show all 77 references

Sorted by citations

Items 701–792 of 792

Additional file 12 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693877
Additional file 14 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693883
Additional file 3 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693850
Additional file 13 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693880
Additional file 2 of GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers
Sathe, A., Ayala, C. I., Bai, X., Grimes, S. M., Lee, B., Kin, C., Shelton, A. A., Poultsides, G. A., & Ji, H. P. (2024) · Figshare · doi:10.6084/m9.figshare.24636707
Additional file 7 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693862
Additional file 2 of Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer
Fan, X., Qi, A., Zhang, M., Jia, Y., Li, S., Han, D., & Liu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26942532
Additional file 8 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693865
Additional file 6 of Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550826
Self-citation
Additional file 1 of Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing
Zhu, L., Li, H., Peng, X., Li, Z., Zhao, S., Wu, D., Chen, J., Li, S., Jia, R., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720176
Additional file 1 of Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Leon-Ferre, R. A., Whitaker, K. R., Suman, V. J., Hoskin, T. L., Giridhar, K. V., Moore, R. M., Al-Jarrad, A., McLaughlin, S. A., Northfelt, D. W., Hunt, K. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26732029
Additional file 1 of Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer
Hu, Y., Lou, X., Zhang, K., Pan, L., Bai, Y., Wang, L., Wang, M., Yan, Y., Wan, J., Yao, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26341933
Additional file 2 of Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing
Zhu, L., Li, H., Peng, X., Li, Z., Zhao, S., Wu, D., Chen, J., Li, S., Jia, R., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720327
Additional file 3 of Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing
Chen, Y., Yin, J., Zhao, L., Zhou, G., Dong, S., Zhang, Y., Niu, P., Ren, H., Zheng, T., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26550814
Self-citation
Additional file 4 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693853
Additional file 3 of Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing
Zhu, L., Li, H., Peng, X., Li, Z., Zhao, S., Wu, D., Chen, J., Li, S., Jia, R., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26714215
Additional file 2 of Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Figshare · doi:10.6084/m9.figshare.26693847
Shaping of the Clinical Landscape of Immunotherapy by PD-L1 Expression in Breast Cancer
Terrero, D., Shanker, A., Tiwari, A. K., & Raman, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_176
Analysis of intratumoral immune heterogeneity reveals spatial organisation of immunosuppression in breast cancerPreprint
Metoikidou, C., Bonté, P., Karnaukhov, V. K., Lesage, L., Djerroudi, L., Nicolas, A., Sirven, P., Vincent‐Salomon, A., Lantz, O. J., Romano, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.18.694622
Integrated transcriptome study reveals a stress response state CD4 +T cells related to immune tolerance in breast cancer
Gu, J.-Y., Qi, Q., Mao, X., Cong, R., Sun, Y., Tang, X.-Y., Guan, X., Wang, J., Yu, M.-X., Wang, S., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02205-4
Self-citation
Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment
Xu, J., Qian, L., Zhou, M., Chen, Q., Peng, J., Liang, Q., Zhang, D., Zhou, H., & Yi, W. (2026) · Advanced Science · doi:10.1002/advs.202516703
CMSS1 promoted CXCL8-CXCR1/2 pathway to accelerate the invasion and immune escape of triple-negative breast cancer
Ding, D., Li, M., Guo, X., Wu, G., & Zhang, Y. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-025-10692-0
Self-citation
Decoding the tumor microenvironment remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblasts in lung adenocarcinoma immunotherapy: elucidation from pan-cancer spatially single-cell transcriptomics landscape
Li, S., Weng, K., Yan, L., Lu, Y., Zhou, R., Fan, Z., Yang, Z., Yue, J., & Li, W. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07677-2 · Cited by 1
A Pan‐Cancer Microenvironment Atlas Constructed by DECEPTICONx
Gu, Y., Deng, F., Gao, L., Chen, Z. C., Chen, J., Wu, J., Xia, Z., Li, Z., Cheng, F., Chen, J., et al. (2026) · iMetaMed · doi:10.1002/imm3.70026
scTREND: An annotation-free single-cell time-resolved and condition-dependent hazard modelPreprint
Yuki, S., Mizukoshi, C., Abe, K., & Shimamura, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701686
Identification and Validation of a Novel Theranostic Target in Triple Negative Breast Cancer with Transcriptomics and Protein Analyses
Lee, H., Kim, G. S., Kim, M. K., Kim, J. L., Jung, K.-H., & Lee, K.-H. (2026) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s568001
Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapyPreprint
Minowa, T., Keshari, S., He, S., Saha, A., Shavkunov, A. S., Pineda, J. E., Yeo, Y. Y., Zhu, B., Mohanty, V., Jindal, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.703136
Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients
Zhang, Z., Yang, Y., Bai, G., Xue, C., & Zhang, X. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1751029
Self-citation
A Single-Cell Atlas of Pan-Cancer Liver Metastasis Reveals Dynamic Cellular Programs Driving Metastatic Progression and Immune Modulation
Tong, X., Chao, H., Zhang, C., Li, Z., Han, Q., Wang, L., Wu, N., Chen, R., Gao, J., Zhang, S., et al. (2026) · Research · doi:10.34133/research.1208
Relationship Between Gene Expression and Drug Response in Triple-Negative Breast Cancer: Leveraging Single-Cell RNA Sequencing and Machine Learning to Identify Biomarker ProfilesPreprint
Mohammadi, K., Afhami, N., Saniotis, A., Henneberg, M., Bagheri, M., & Kavousi, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.05.709737
Deciphering the Effect of Methyl 4-Hydroxybenzoate on Breast Cancer by Bioinformatics and Experiments
Mu, Y., Zeng, X., Yang, Z., Duan, Y., Su, H., Zhu, L., Liu, H., Xu, M., Wang, B., Hong, W., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c11680
Spatio-temporal mapping of immune cell dynamics during human sequential lymph node metastasisPreprint
Zhao, Q., Lu, Y., Shi, Z., Zhang, H., Li, C. S., Zhao, R., Ling, Y., Gao, Y., Zhang, Z., Sun, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712495
Self-citation
Integrated single-cell and spatial mapping coupled with machine learning unveils core stemness landscapes and regulatory drivers in triple-negative breast cancer
Huo, Z., Sun, W., Lou, C., & Yang, T. (2026) · Discover Oncology · doi:10.1007/s12672-026-04824-5
Local Anti-CTLA4 Cancer Immunotherapy From Bench to Bedside
Tselikas, L. (2021) · theses.fr (ABES) · doi:10.70675/7e1fa4d8z5408z419bz9394z19ae17697026
CD8+ T cell differentiation towards exhaustion in human cancer
Metoikidou, C. (2022) · theses.fr (ABES) · doi:10.70675/a9c41d93z98c7z40e0z80eczc8c778ad87ac
Unsupervised representation learning for single-cell transcriptomic and epigenomic data
Raimundo, F. (2022) · theses.fr (ABES) · doi:10.70675/760cd5d0z17c6z4f4ezb476z68bd387daf22
KLRG1 identifies circulating cytotoxic CD4 T cells with selective anti-tumor function in human cancerPreprint
Cenerenti, M., Garnica, J., Saillard, M., Gueguen, P., Wolf, B., Lemaître, F., Marone, R., Liu, Y., Cornu, A., Dumez, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.13.718113
Single‐Cell Transcriptomics Reveals the Potential Role of GZMK+ CD8+ T Cells in Cell Senescence of Triple‐Negative Breast Cancer
Zhou, D., Hu, T., Beibei, X., Zhu, J., Ma, M., Zhang, W., Xie, L., Ouyang, Z., Xu, Y., & Su, Y. (2026) · International Journal of Genomics · doi:10.1155/ijog/4215646
Self-citation
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Yu, K., Tidwell, R. S. S., Bathala, T. K., Sheth, R. A., Karki, M., Chen, J., Qian, J., Duan, F., Perelli, L., Soeung, M., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-4518
Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo
Cheng, X., Chen, W., Hao, W., Guo, Y., Zhang, J., Song, C., He, Z., Wu, H., & Yao, D. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118680
Comparative Analysis of Tumor‐Immune Microenvironment Diversity Among Biopsy, Resection, and Metastatic Colorectal Cancer Specimens
Liu, Q., Liu, W. T., Zhang, C., Gao, Y., Feng, D., Deng, D., & Pan, Y. (2026) · Journal of Immunology Research · doi:10.1155/jimr/9281559
Investigate the heterogeneity of colorectal cancer patients at the single-cell level prior to and subsequent to immunotherapy
Zhao, H., Gao, W., Zhao, J., Wang, Q., Cheng, W., Li, J., & Yang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1840165
LGALS1 drives chemoresistance in esophageal squamous cell carcinoma by modulating epithelial-mesenchymal transition and tumor immunity
Yan, Q.-H., Xu, C., Zhen-guo, L., Zheng, Y.-Z., Wong, W.-S., Liang, D.-C., Yang, J., Chang, W.-G., & Wang, J.-Y. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i18.114713
Clonal Lineage Tracing Reveals Distinct Invasive Subpopulations in Triple-Negative Breast Cancer
Santiago, C. D., Gardner, A. L., Parker, P., Thomas, J. R., Callahan, G. P., Ghosh, M., Baker, A. B., & Brock, A. (2026) · Tissue Engineering Part C Methods · doi:10.1177/19373384261432668
Single-Cell Analysis for Cancer
Ding, Z., & Shen, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-9789-5_10
Monocyte-derived macrophages promote intraepithelial infiltration of effector memory CD8 + T cells in tumors regressing after STING agonist treatmentPreprint
Vermare, A., Ventura, A., Rouault, A., Simula, L., Seradj, M., Lhuillier, L., Weber-Delacroix, E., Mulder, K., Vimeux, L., Espie, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.728475
Circadian misalignment underlies immune escape in breast cancerPreprint
Liang, C., Liu, Z., Xu, X., Xu, Z., Zhang, Q., Zhang, T., Mangan, R. J., Xiu, B., Wu, G., Akhshi, T. K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.726543
Self-citation
Single‐Cell Analysis Identifies LYPD6B as a Tumor‐Intrinsic Candidate Associated With Immunotherapy Nonresponse in Breast Cancer
Wang, Y., Quan, H., Xu, Z., Wang, Y., & Wang, Z. (2026) · Thoracic Cancer · doi:10.1111/1759-7714.70311
Self-citation
Hierarchical classification of immune cell transcriptomes at population-scalePreprint
Beltz, C., Qiu, Z., Sadowski, L., Kraske, J. A., Aggarwal, A., Quintanal-Villalonga, À., Manoj, P., Littbarski, A., Bajaj, S., Meškauskaitė, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.30.728980 · Cited by 1
Pan-cancer single-cell and spatial transcriptomics analyses delineate response-associated heterogeneity and therapeutic targets of tumor-infiltrating B cells following immune checkpoint blockade
Fang, J., Liu, H., Lei, J., Chen, Y., & Wang, J. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04449-1
Paclitaxel prodrug loaded high-density lipoprotein nanoparticles for chemoimmunotherapy of triple-negative breast cancer
Jiang, L.-Y., Zhu, B.-Y., Zhou, L., Deng, D., Zhang, X.-Y., Chen, J., Jiang, P.-W., Wang, G.-R., Yang, Q.-M., Zhang, M.-H., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01847-0
TKI resistance is associated with immune dysfunction in ccRCCPreprint
Jonasch, E. W., Liu, X.-D., He, H., Liu, J., Karpinets, T. V., Zhang, X., Hoang, A. G., Karam, J. A., Woodman, S. E., & Sircar, K. (2026) · Research Square · doi:10.21203/rs.3.rs-9657194/v1
Macrophage Plasticity: Phenotypic and Functional Profiles Across Pathological Microenvironments
Falda, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125333
Emerging Perspectives on How Metallic Nanoparticles and Their Oxide Forms Interact with the Tumor Microenvironment
Caro, C. (2026) · Processes · doi:10.3390/pr14121977
Cancer-Intrinsic Protein Neddylation Modulates the Intratumoral Immune Landscape to Constrain Immune Checkpoint Blockade Therapy
Papakyriacou, I., Lu, Y., Jarvius, M., Lapins, M., Puigvert, J. C., & Mao, Y. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1309
Decoding the immunometabolic landscape identifies SLC7A5 as a vulnerability in chemo-immunotherapy resistant TNBC
Zhong, S., Yu, B., Zhou, S., Chen, W., Liu, F., Zhu, H., Min, F., & Qian, F. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02231-2
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells
Tsai, A. K., Lozada, J. R., Kennedy, P. R., Moline, D. R., Pandey, R., Lyons, R. C., Luo, C., Wang, R., Arafa, A. T., Femino, E. L., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102889
Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.
Landberg, G., Ståhlberg, M., Frisk, E., Ruiz-Martínez, S., Kaya, M., Rydholm, M., Martner, A., Helou, K., Ståhlberg, A., & Garre, E. (2026) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2026.119649
Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment
CHEN, W., Cheng, X., Zhao, X., Chen, Z., Lai, Y., Hao, W., He, Z., Lin, W., Wu, Y., Guo, Y., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00487
Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells
Cepika, A., Amaya, L., Waichler, C., Narula, M., Mantilla, M., Thomas, B. C., Chen, P. P., Freeborn, R. A., Pavel-Dinu, M., Nideffer, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec6358 · Cited by 3
Therapeutic platforms for cancer management centered on blocking the PD-L1/PD-1 interaction through the use of aptamers: A review
Marvizadeh, A., Sameiyan, E., Najjarkar, A. T., Alibolandi, M., Ramezani, M., Abnous, K., & Taghdisi, S. M. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153537
Task-Aware Benchmarking of Batch Correction Methods for scRNA Triple-Negative Breast Cancer Atlas Construction
Scheible, P., He, J., Tang, A. H., & Sun, J. (2026) · Lecture notes in computer science · doi:10.1007/978-981-92-3719-7_3
Latest advances in nanodrug delivery systems for modulating the immune microenvironment in triple-negative breast cancer
Dong, X., Cui, F., Wang, L., WU, M., Liu, Y., Gao, L., Xie, J., Lin, X., Sun, J., Zhou, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793737 · Cited by 2
Single‐Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma
Li, H., Sun, C., & Yang, M. (2026) · International Journal of Genomics · doi:10.1155/ijog/4040246
Dynamic regulation of lysine and arginine metabolism promotes immune evasion by limiting T cell function in cancer
Yu, W., Sun, R., Lu, X., Deng, Q., Zhang, H., Chen, S., Dai, S., Hu, T., Li, X., Yang, Y., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aeb7315
Self-citation
Single-cell profiling defines cellular ecosystems and malignant cell state coupling across pan-cancer tumor microenvironments
Yang, X., Yang, T., Wang, Y., Xie, P., Li, X., Yuan, J., & Yang, Y. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02741-3
Self-citation
Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications
Cao, Y., Cai, J., Dai, D., Wang, J., Zhang, Y., Xiong, J., Huang, H., Gao, Y., Xia, Y., Liu, F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76152-9
Self-citation
Peptide–drug conjugates in breast cancer therapy: Emerging targets, translational challenges, and optimization strategies
Zhang, H., Xue, W., Wang, J., Wang, B., Hong, J., & Yang, M. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.104997
Transcriptomic Association of COL3A1 + Fibroblasts With Mechanical Pain–Related Gene Signatures in Triple‐Negative Breast Cancer
Zhong, Y., Sun, Q., & Sun, C. (2026) · Pain Research and Management · doi:10.1155/prm/8480126
Integrated Single-Cell and Bulk RNA-Sequencing Analysis Identifies an Aging-Related Gene Signature for Prognosis in Breast Cancer
Chen, P., Lin, Y., Li, J., Gu, Y., & Zhang, X. (2026) · Genes · doi:10.3390/genes17080921
From the invasive front to organotropic pre-metastatic niches: spatial immune regulatory networks governing cholangiocarcinoma dissemination and metastasis-intercepting immunotherapy
Zhang, L., Zhang, K., Chen, Z., & Lu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1919864
Spatial immune biomarkers in triple-negative breast cancer: emerging evidence, technology trade-offs, and barriers to clinical translation
Zeng, L., Lin, W., Xue, S., Chen, M., & Wu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1899098 · Cited by 1
GTPase RAB31 supports ANXA1-driven macrophage education through clathrin-mediated endocytosis to suppress antitumor immunity
Liu, J., Wang, S., Bao, D., Dong, G., Ma, Y., Zhang, G., Liu, X., Zhang, D., Wang, L., Xu, S., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015703
CD55 organizes lipid raft-LCK signaling to potentiate NK-cell antitumor immunity
Li, L., Li, Z., Liu, Y., Fan, W., Lei, Y., Tian, L., Chen, L., Qu, Z., Shi, Y., Yu, J., et al. (2026) · Cell Research · doi:10.1038/s41422-026-01288-8
Self-citation
Non-coding RNA 7SK drives tumor resistance by coupling local oncogenic activation with global transcriptional repression
Xu, P., Luo, Z., Chen, X., Yuan, Z., Cheng, L., Yang, Y., Lin, H., Zhang, Q., & Qin, P. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014749
Molecular subgroups and biomarker guided precision immunotherapy in triple-negative breast cancer: advances, challenges, and future directions
Peng, S., Qin, M., Song, G., 毛庆龙, Liu, Z., & Nie, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1859601
Self-citation
FOXP1 Knockdown Reprograms Th9 CAR‐T Cells to Overcome Antigen Escape
Zhu, Y., Xie, X., Wu, X., Ouyang, S., Zhou, Y., Wen, K., Zhong, Y., Chen, Y., Wang, H., Gao, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.77564
Rejuvenating endogenous antitumor immunity via a chimeric receptor-engineered oncolytic virus targeting tumor-associated macrophages
Lin, C., Li, S., Lou, R., Teng, W., Tian, Y., Feng, C., Wang, N., Rao, Y., Qin, Y., Li, L., et al. (2026) · Science Advances · doi:10.1126/sciadv.aef6767
Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemoimmunotherapy in triple-negative breast cancer
Mesrizadeh, Z., Mukund, K., & Subramaniam, S. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag049
AI-driven multi-omics integration in breast cancer: clinical applications, immunotherapy prediction, and translational challenges
Wang, Z.-Y., Liu, N., & Chen, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1875788
Disruption of the ARID1A-containing SWI/SNF complex reprograms tumor-associated macrophages and enhances immunotherapy responsePreprint
McRae, H. M., Nguyen, K. M., Vallmajó-Martín, Q., Rivera, S. A., Stevenson, B. T., Evensen, K. G., Burns, M. J., Bell, J. C., Mandias, H. C. R., Chick, B. Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.25.754528
Targeting Drug-Tolerant Persister Cells in Cancer: Progress From Modeling to Targeting Fragility Studies
郑衍平, Deng, X., Su, Y., CHIEN, J. R., & Liang, M. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49637
Antitumor efficacy of PD-1 blocking antibody is enhanced through liposomal delivery and myeloid immune modulation
Islam, M. R., Patel, J., Back, P. I., Modaresahmadi, S., Markiewski, M. M., Triplett, T., & La-Beck, N. M. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115428
Nucleus-targeted silencing of EPIC1 expression as an epigenetic strategy to modulate tumor immune microenvironment and potentiate cancer immunotherapy
Huang, L., Xu, R., Lin, C., Liu, M., Zhuo, X., Zhao, Z., Li, R., Chen, J., & Xu, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115441
Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integration
Wu, J.-N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1911879
Macrophage- or neutrophil-expressed UPP1 drives tumor growth and immune suppression in the tumor microenvironment
Li, Y., Ran, Q., Xiong, A., Jiang, M., Xu, F., Wei, Y., Gu, J., Li, G., Ge, D., & Lu, C. (2026) · Science Advances · doi:10.1126/sciadv.aea8798
Revealing pan-cancer clonal niches of T cells from single-cell RNA sequencing using contrastive learningPreprint
Shorer, O., Pinhasi, A., Amit, R., & Yizhak, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.06.757206
B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice
Wang, F., Lim, E. B., Mehta, R., & Wu, Y. L. (2026) · Cell Biology International · doi:10.1002/cbin.70227
CXCR5 regulates CD8+/GZMB+ T cell infiltration and apoptotic signaling in breast cancer
Feng, W., Yan, J., Gong, X., Hu, J.-D., Jin, M.-L., Ma, C.-H., & Li, F.-G. (2026) · iScience · doi:10.1016/j.isci.2026.117874
Reprogramming tumor-associated macrophages in breast cancer: from myeloid plasticity and tumor-promoting programs to CAR-macrophage therapy
Heydari, F., Derakhshani, M., & Naghinezhad, J. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01861-z
Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab
Nomura, K., Fukami, T., Kato, S., Tanaka, S., Fukuda, A., Koike, Y., Kondo, M., Kumagai, K., Irie, T., Okumura, G., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.09.016
The HLA-E–NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target
Li, L., Han, X., Lu, L., Liu, K., Li, Y., & Su, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.2001812

Authors: Zhang, Y., Chen, H., Mo, H., Hu, X., Gao, R., Zhao, Y., Liu, B., Niu, L., Sun, X., Yu, X., Wang, Y., Chang, Q., Gong, T., Guan, X., Hu, T., Qian, T., Xu, B., Ma, F., Zhang, Z., & Liu, Z.
Affiliations: Peking University (CN)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
Corresponding author: Xu, Binghe
Ma, Fei
Zhang, Zemin
Liu, Zhihua
ORCID: Zhang, Yuanyuan
Chen, Hongyan
Mo, Hongnan
Hu, Xueda
Gao, Ranran
Zhao, Yahui
Liu, Baolin
Niu, Lijuan
Sun, Xiaoying
Yu, Xiao
Wang, Yong
Chang, Qing
Gong, Tongyang
Qian, Tianyi
Xu, Binghe
Ma, Fei
Zhang, Zemin
Liu, Zhihua
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2021-12
Volume: 39
Issue: 12
Pages: 1578-1593.e8
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccell.2021.09.010
OpenAlex: W3205385275
Cited by: 783
References: 77
Citations by year: 2026: 135 · 2025: 206 · 2024: 183 · 2023: 158 · 2022: 93 · 2021: 8
FWCI: 41.16
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Cancer Cell (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (31991171, 81988101, 82030089, 91942307)
Chinese Academy of Meteorological Sciences (2016-I2M-1-001, 2017-I2M-3-004, 2019-I2M-1-003)
Peking University
Beijing Municipal Science and Technology Commission (Z201100005320014)
National Key Research and Development Program of China (2018YFC1312101, 2020YFA0803300)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: triple-negative breast cancer, PD-L1 blockade, atezolizumab, paclitaxel, immune cell dynamics, lymphoid tissue inducer cells, follicular B cells, conventional type 1 dendritic cells, single-cell RNA sequencing, single-cell ATAC-seq
MeSH terms: Immune Checkpoint Inhibitors, Female, Humans, Single-Cell Analysis, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks